Overview

Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To investigate the feasibility of preoperative chemoradiation with oxaliplatin plus capecitabine, with or without prior induction chemotherapy in patients with locally advanced or marginally resectable rectal cancer with resectable synchronous liver metastases.
Phase:
Phase 2
Details
Lead Sponsor:
Asan Medical Center
Treatments:
Capecitabine
Oxaliplatin